Inventor · disambiguated record
Edward A. Neuwelt
Also filed as: NEUWELT EDWARD · NEUWELT EDWARD A
8 granted patents·15 pending applications·345 citations·filing 1987–2023
88Inventor score
Files withUNIV OREGON HEALTH & SCIENCE12NEUWELT EDWARD A4OREGON STATE3US GOV VETERANS AFFAIRS3US DEPT VETERANS AFFAIRS1
Top patents by PatentIndex Score
23 records- 0195US4866042AMethod for the delivery of genetic material across the blood brain barrierNEUWELT EDWARD A·Filed 1987·Granted Sep 12, 1989·200 cites·6 claims
- 0290US10596190B2Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapyNEUWELT EDWARD A·Filed 2018·Granted Mar 24, 2020·10 cites·1 claims
- 0387US5059415AMethod for diagnostically imaging lesions in the brain inside a blood-brain barrierOREGON STATE·Filed 1989·Granted Oct 22, 1991·70 cites·6 claims
- 0483US2023390330A1Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapyUNIV OREGON HEALTH & SCIENCE·Filed 2023·Application pending·0 cites
- 0581US2023270776A1Method for Reducing Ototoxicity in Pediatric Patients Receiving Plantinum-Based ChemotherapyUNIV OREGON HEALTH & SCIENCE·Filed 2023·Application pending·0 cites
- 0680US7022315B2Administration of a thiol-based chemoprotectant compoundUS DEPT VETERANS AFFAIRS·Filed 2001·Granted Apr 4, 2006·19 cites·2 claims
- 0778US5124146ADifferential delivery of therapeutic agents across the blood brain barrierOREGON STATE·Filed 1991·Granted Jun 23, 1992·43 cites·7 claims
- 0877US2022280560A1Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapyUNIV OREGON HEALTH & SCIENCE·Filed 2022·Application pending·0 cites
- 0971US2020038436A1Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapyNEUWELT EDWARD A·Filed 2019·Application pending·0 cites
- 1067US10857174B2Morpholino oligonucleotides useful in cancer treatmentUS GOV VETERANS AFFAIRS·Filed 2019·Granted Dec 8, 2020·0 cites·18 claims
- 1162US11679121B2Morpholino oligonucleotides useful in cancer treatmentUS GOV VETERANS AFFAIRS·Filed 2020·Granted Jun 20, 2023·0 cites·20 claims
- 1259US2020000844A1Administration of a thiol-based chemoprotectant compoundUNIV OREGON HEALTH & SCIENCE·Filed 2019·Application pending·0 cites
- 1356US2018289737A1Administration of a thiol-based chemoprotectant compoundUNIV OREGON HEALTH & SCIENCE·Filed 2018·Application pending·0 cites
- 1453US2004198841A1Use of thiol-based compositions in ameliorating mucosal injuryUNIV OREGON HEALTH & SCIENCE·Filed 2004·Application pending·0 cites
- 1552US2006177523A1Administration of a thiol-based chemoprotectant compoundUS GOV VETERANS AFFAIRS·Filed 2005·Application pending·0 cites
- 1652US2017182089A1Administration of a thiol-based chemoprotectant compoundUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 1749US2016184353A1Administration of a thiol-based chemoprotectant compoundUNIV OREGON HEALTH & SCIENCE·Filed 2015·Application pending·0 cites
- 1847US2004132666A1Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuriesUNIV OREGON HEALTH & SCIENCE·Filed 2003·Application pending·0 cites
- 1947US2004146585A1Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopeniaUNIV OREGON HEALTH & SCIENCE·Filed 2003·Application pending·0 cites
- 2044US2006020035A1Bone marrow protection with N-acetyl-L-cysteineUNIV OREGON HEALTH & SCIENCE·Filed 2005·Application pending·0 cites
- 2141US2011046482A1Methods for reducing toxicities associated with medical procedures employing radiographic contrast agentsUNIV OREGON HEALTH & SCIENCE·Filed 2007·Application pending·0 cites
- 2240US2004062764A1Chemoprotectant for gastric toxicityNEUWELT EDWARD A·Filed 2001·Application pending·0 cites
- 2325US5200508ACell surface antigen that binds with L6 monoclonal antibodyOREGON STATE·Filed 1991·Granted Apr 6, 1993·3 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Edward A. Neuwelt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →